Skip to main content
. 2015 May 18;8:241–253. doi: 10.2147/DMSO.S77290

Figure 3.

Figure 3

Occurrence of gastrointestinal-related adverse events over time with exenatide QW treatment. Incidences of nausea, vomiting, and diarrhea in patients treated with exenatide QW are combined for weeks 0–12 in 2-week increments.1421

Abbreviation: QW, once weekly.